ArticleScientific reports2026
A multi-method integrated weighting framework for biosafety risk assessment of infectious substances.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Biosafety risk assessment of infectious substances in cross-border movement is essential for preventing biosecurity threats and supporting regulatory decision-making. However, existing approaches often rely either on subjective expert judgment or purely objective data, making it difficult to effectively integrate heterogeneous information sources. This study proposes a multi-method integrated weighting framework for cross-border biosafety risk assessment by combining the Fuzzy Analytic Hierarchy Process (FAHP), Principal Component Analysis (PCA), and an integrated TOPSIS-GRA evaluation model.In the proposed framework, FAHP and PCA are used to derive subjective and objective indicator weights, respectively. The discrepancies between different weighting results are explicitly characterized, and a constrained deviation-minimization optimization model is constructed to reconcile heterogeneous weighting information and obtain a combined weight vector under normalization constraints. The integrated TOPSIS-GRA model is then applied to quantify biosafety risks by jointly considering the distance from ideal solutions and grey relational similarity. A scenario-based case study on cross-border infectious substances demonstrates that the proposed framework improves the consistency, robustness, and interpretability of biosafety risk evaluation. The results indicate that the proposed approach provides a structured and reproducible tool for multi-criteria decision-making under uncertainty and offers practical support for biosafety management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.